pubmed-article:18398808 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18398808 | lifeskim:mentions | umls-concept:C0086287 | lld:lifeskim |
pubmed-article:18398808 | lifeskim:mentions | umls-concept:C0037315 | lld:lifeskim |
pubmed-article:18398808 | lifeskim:mentions | umls-concept:C0028754 | lld:lifeskim |
pubmed-article:18398808 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
pubmed-article:18398808 | lifeskim:mentions | umls-concept:C0010362 | lld:lifeskim |
pubmed-article:18398808 | lifeskim:mentions | umls-concept:C0754710 | lld:lifeskim |
pubmed-article:18398808 | lifeskim:mentions | umls-concept:C0669479 | lld:lifeskim |
pubmed-article:18398808 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:18398808 | pubmed:dateCreated | 2008-4-9 | lld:pubmed |
pubmed-article:18398808 | pubmed:abstractText | Sleep-disordered breathing (SDB) is often encountered in morbid obesity (MO) in conjunction with insulin resistance (IR). Aminoterminal pro-brain natriuretic peptide (NT-proBNP) is a promising marker for left ventricular dysfunction (LVD) in MO. We sought to explore the factors that may influence the relationships of SDB and IR with NT-proBNP in MO women. We performed a cross-sectional pilot study involving 110 asymptomatic MO (44.5+/-0.7 kg/m2) young women. SDB risk was assessed using a modified version of the Berlin Questionnaire (BQ). IR was assessed using the homeostasis model assessment (HOMA) index and adiponectin levels. LVD was assessed using NT-proBNP and echocardiograms. In this study, NT-proBNP levels and LVD increased significantly along the BQ strata. Multiple regression analysis identified BQ and log-transformed HOMA as the independent variables predicting as much as 48.0% of the variability of logNT-proBNP. In conclusion, NT-pro-BNP levels are independently predicted by SDB and IR in asymptomatic MO women. Larger prospective studies are warranted. | lld:pubmed |
pubmed-article:18398808 | pubmed:language | eng | lld:pubmed |
pubmed-article:18398808 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18398808 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18398808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18398808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18398808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18398808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18398808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18398808 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18398808 | pubmed:month | Mar | lld:pubmed |
pubmed-article:18398808 | pubmed:issn | 1479-1641 | lld:pubmed |
pubmed-article:18398808 | pubmed:author | pubmed-author:JosephP MPM | lld:pubmed |
pubmed-article:18398808 | pubmed:author | pubmed-author:PlanasFrances... | lld:pubmed |
pubmed-article:18398808 | pubmed:author | pubmed-author:YbarraJuanJ | lld:pubmed |
pubmed-article:18398808 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18398808 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:18398808 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18398808 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18398808 | pubmed:pagination | 19-24 | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:meshHeading | pubmed-meshheading:18398808... | lld:pubmed |
pubmed-article:18398808 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18398808 | pubmed:articleTitle | Aminoterminal pro-brain natriuretic peptide (NT-proBNP) and sleep-disordered breathing in morbidly obese females: a cross-sectional study. | lld:pubmed |
pubmed-article:18398808 | pubmed:affiliation | Instituto de Cardiología y Medicina Avanzada , Centro Médico Teknon, C/ Vilana 12, 08021 Barcelona, Spain. juanybarra@hotmail.com | lld:pubmed |
pubmed-article:18398808 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18398808 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18398808 | lld:pubmed |